Supplemental Figure S3 from Evolutionary Antifragile Therapy is a Treatment Strategy to Suppress Drug Resistance by Exploiting Dose–Response Convexity | AMiner
Supplemental Figure S3 from Evolutionary Antifragile Therapy is a Treatment Strategy to Suppress Drug Resistance by Exploiting Dose–Response Convexity
Relationship between inflection point and IC50. (A) As the steepness parameter, n, increases the true inflection point (x*; blue) approaches the IC50 value (red). (B) The relation between inflection and IC50 is shown here as a function of n.